Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Federico Bardazzi and Annalisa Patrizi.
Federico Bardazzi
Connection Strength
5.868
Annalisa Patrizi
  1. How infodemic during the COVID-19 outbreak influenced common clinical practice in an Outpatient Service of Severe Psoriasis. Dermatol Ther. 2020 11; 33(6):e14065.
    View in: PubMed
    Score: 0.225
  2. Rituximab: a safe therapeutic option during the COVID-19 pandemic? J Dermatolog Treat. 2020 Jul 29; 1.
    View in: PubMed
    Score: 0.224
  3. Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):e295-e297.
    View in: PubMed
    Score: 0.223
  4. Can COVID-19 be a sexually transmitted disease? Posterity will judge. Dermatol Ther. 2020 Jul; 33(4):e13676.
    View in: PubMed
    Score: 0.222
  5. The COVID-19 outbreak in Italy: Preventive and protective measures adopted by the Dermatology Unit of Bologna University Hospital. Dermatol Ther. 2020 Jul; 33(4):e13469.
    View in: PubMed
    Score: 0.222
  6. Merkel cell carcinoma: a prompt diagnosis to increase survival. J Eur Acad Dermatol Venereol. 2019 Dec; 33(12):e478-e480.
    View in: PubMed
    Score: 0.209
  7. Mucous Membrane Pemphigoid-Associated Malignancies: Case Series and a Brief Overview of the Literature. Dermatol Pract Concept. 2019 Apr; 9(2):119-125.
    View in: PubMed
    Score: 0.205
  8. Etanercept for pemphigus vulgaris. Ital J Dermatol Venerol. 2021 12; 156(Suppl. 1 to No. 6):10-11.
    View in: PubMed
    Score: 0.201
  9. EPIFIBROIN 0039 dressing and powder as a therapeutic aid for erosive and ulcerated dermatoses of the skin and mucosa: an investigative study. Eur J Dermatol. 2018 Dec 01; 28(6):844-845.
    View in: PubMed
    Score: 0.199
  10. Does chronic immunosuppressive therapy for autoimmune disease influence the risk of developing active tuberculosis? Dermatol Ther. 2019 01; 32(1):e12777.
    View in: PubMed
    Score: 0.199
  11. Rituximab therapy in pemphigus: A long-term follow-up. Dermatol Ther. 2019 01; 32(1):e12763.
    View in: PubMed
    Score: 0.198
  12. Apremilast as therapeutic option in a HIV positive patient with severe psoriasis. Dermatol Ther. 2018 11; 31(6):e12719.
    View in: PubMed
    Score: 0.198
  13. Reinventing the wheel: a simple topical treatment for psoriasis. G Ital Dermatol Venereol. 2018 Oct; 153(5):737-738.
    View in: PubMed
    Score: 0.197
  14. Idiopathic granulomatous vulvitis and subsequent oral granulomatosis: a diagnostic and therapeutic challenge. Clin Exp Dermatol. 2019 03; 44(2):229-231.
    View in: PubMed
    Score: 0.197
  15. Dermatophytosis in a psoriatic patient treated with secukinumab: an underrated adverse effect? G Ital Dermatol Venereol. 2018 Aug; 153(4):590-591.
    View in: PubMed
    Score: 0.195
  16. Recalcitrant and recurrent bacterial folliculitis during anti-IL 17 therapy in a psoriatic patient. G Ital Dermatol Venereol. 2020 Apr; 155(2):247-248.
    View in: PubMed
    Score: 0.194
  17. Cutaneous complications of immunosuppression in 812 transplant recipients: a 40-year single center experience. G Ital Dermatol Venereol. 2020 Oct; 155(5):662-668.
    View in: PubMed
    Score: 0.194
  18. Angiokeratoma corporis diffusum mit normaler Enzymaktivität: drei neue Fälle aus Italien. J Dtsch Dermatol Ges. 2018 Jun; 16(6):769-771.
    View in: PubMed
    Score: 0.193
  19. Angiokeratoma corporis diffusum with normal enzyme activity: three new Italian cases. J Dtsch Dermatol Ges. 2018 06; 16(6):769-771.
    View in: PubMed
    Score: 0.192
  20. Infantile digital fibromatosis-like tumor of adult. G Ital Dermatol Venereol. 2018 02; 153(1):116-118.
    View in: PubMed
    Score: 0.188
  21. The risk of melanoma in patients treated with anti-TNFa: does it exist? G Ital Dermatol Venereol. 2018 02; 153(1):119-120.
    View in: PubMed
    Score: 0.188
  22. Cyclosporine in clinical practice: a retrospective study comparing fixed dose and body weight-based dose regimens in psoriatic patients. G Ital Dermatol Venereol. 2020 Apr; 155(2):146-149.
    View in: PubMed
    Score: 0.188
  23. When it rains it pours: coexistence of autoimmune bullous disease and plaque psoriasis in Caucasian patients. G Ital Dermatol Venereol. 2019 Jun; 154(3):368-370.
    View in: PubMed
    Score: 0.188
  24. Secukinumab in multi-failure psoriatic patients: the last hope? J Dermatolog Treat. 2018 Sep; 29(6):583-585.
    View in: PubMed
    Score: 0.188
  25. Can taurine energy drink worsen psoriasis? G Ital Dermatol Venereol. 2017 10; 152(5):544-545.
    View in: PubMed
    Score: 0.184
  26. Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience. Acta Derm Venereol. 2017 Aug 31; 97(8):989-990.
    View in: PubMed
    Score: 0.183
  27. Risk of malignancy in psoriatic patients: Our clinical experience. Dermatol Ther. 2017 Jul; 30(4).
    View in: PubMed
    Score: 0.176
  28. Survey of bullous pemphigoid in an Italian university hospital: clinical-epidemiological characteristics and follow-up. G Ital Dermatol Venereol. 2018 Oct; 153(5):613-618.
    View in: PubMed
    Score: 0.175
  29. Does biological therapy affect interferon-? release assay response? A long-term follow-up of patients with psoriasis using QuantiFERON-TB. Br J Dermatol. 2015 Mar; 172(3):798-800.
    View in: PubMed
    Score: 0.153
  30. Pityriasis versicolor during anti-TNF-a monoclonal antibody therapy: therapeutic considerations. Mycoses. 2012 Sep; 55(5):444-6.
    View in: PubMed
    Score: 0.124
  31. Treatment of severe psoriasis in children: recommendations of an Italian expert group. Eur J Pediatr. 2017 Oct; 176(10):1339-1354.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.